The Alpestria-1 study enrolled (in France, USA and Spain) 26 patients with Alport syndrome at high risk of a rapid loss of kidney function despite stable multiple SoC drugs, including ...

The firm began a Phase II study of evorpacept in HER2-positive breast cancer patients and began testing a higher dose of ALX2004 in a separate Phase I trial.

First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...

Making medical policy based on racial stereotypes harmed all Black Americans waiting for a kidney. This lawsuit is brought by ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

Reduced kidney function is linked to less accurate blood-based biomarkers for Alzheimer disease, underscoring the need to consider kidney health as these tests enter wider clinical use. Reduced kidney ...

Background We examined whether impaired kidney function, identified through elevated levels of urine albumin to creatinine ratio (UACR) or reduced estimated glomerular filtration rate (eGFR), is ...

Oncologists share their treatment preferences for patients with advanced NSCLC with EGFR mutations. Improving survival and quality of life for patients with NSCLC is of the utmost importance in the ...

Limited evidence exists to support the simultaneous initiation of sodium–glucose cotransporter-2 inhibitors and finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in persons with ...

BOSTON -- Exposure to high temperatures may be renally taxing for kidney transplant recipients, a researcher reported here. Among nearly 64,000 recipients from 250 transplant centers around the U.S., ...